ABSTRACT. Growth retardation and lactic aciduria are well-known abnormalities in patients with a deficiency of either glucose-6-phosphatase or glucose-6-phosphate translocase. In 19 patients with glucose-6-phosphatase and two patients with glucose-6-phosphate translocase, growth retardation was quantified by calculating the height standard deviation score. The urinary excretion of lactate and some other metabolites was quantified by calculating the lactatelcreatinine, 2-oxoglutarate/creatinine, citratelcreatinine, and glycerollcreatinine ratios in urine. Significant correlations were found between the lacthtelcreatinine ratio, the 2-oxoglutarate/creatinine ratio, and height SD score. Urinary lactate appeared to respond promptly to changes of the diet, while urinary 2-oxoglutarate responded only slowly, as did growth itself. The citratelcreatinine ratio and the glycerollcreatinine ratio were within the normal range and varied little. It was concluded that the urinary 2-oxoglutarate excretion primarily reflects the severity of the disease as expressed in stunted growth. Thus, while urinary lactate levels are more suitable for monitoring the diet, urinary 2-oxoglutarate levels can be used as an indication for intensive treatment with hyperalimentation. (Pediatr Res 21: 279-282,1987) Abbreviations GSD-IA, glycogen storage disease caused by deficiency of glucose-6-phosphatase GSD-IB, glycogen storage disease caused by deficiency of glucose-6-phosphate translocase HSDS, height standard deviation score GDF, gastric drip feeding Since 1975 we treat our patients with GSD-IA by means of GDF during the night (I). Most patients showed spectacular catch-up growth. Some patients, however, were less sensitive to this treatment, and a few were even resistant. Struck by the fact that two patients of the latter category showed excessive urinary excretion of 2-oxoglutarate besides excretion of lactate, we investigated whether the difference~ in growth response of the patients in GDF were reflected by differences in the excretion of particular metabolites in the urine.
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Lactic aciduria has been found in many inborn errors of carbohydrate metabolism. In GSD-IA the urinary lactate excretion appeared to be a useful parameter to estimate the glucose requirement of the patient (2). 2-Oxoglutaric aciduria has been found incidentally in patients with enzyme defects of both the 2-oxoglutarate dehydrogenase complex and the pyruvate dehydrogenase complex (3) (4) (5) and in one patient with GSD-IA and one patient with GSD-IB (6). Urinary citrate excretion has been studied in various inborn errors of metabolism with inconclusive results (6, 7) . Citric acid is a major camer of C2 units from the mitochondria where they are produced from pyruvate during carbohydrate oxidation, to the cytosol, where they are utilized in fatty acid synthesis. Therefore the excretion of citrate in the urine of GSD-I patients may reflect their excessive lipid synthesis. Glycerol was the fourth metabolite whose excretion in urine we determined. Apart from its function in phospholipid and triglyceride synthesis, it is an important substrate for gluconeogenesis (8) . It has been found in high concentrations in the urine of a patient with fructose-l,6-diphosphatase deficiency, which blocks gluconeogenesis (9), so hyperexcretion of glycerol might also occur in patients with GSD-IA and IB in case of deficient availability of glucose.
PATIENTS
We studied 19 patients with GSD-IA and two patients with GSD-IB. The diagnosis was confirmed by enzyme assay of a liver biopsy in all patients except one. In this case, the diagnosis of GSD-IA was inferred from the enzyme defect of his brother. The age of the patients varied from 2 to 16 yr. The dietary treatment (10) consisted of frequent meals, sucrose-restricted and polyunsaturated fats-enriched. The composition was approximately 60-65, 10-15, and 25 energy percent for carbohydrates, proteins, and fats, respectively. GDF administered to 19 patients during 10 to 12 h per night, consisted of a complete infant formula, lactose-restricted, without sucrose and with extra maltodextrin (1). The energy content of GDF contributed approximately 30 to 35% of the total daily energy intake. In two patients with the most severe growth retardation, an experimental diet was introduced in order to improve growth and metabolic abnormalities. The new diet consisted of a high-energy liquid formula of fixed composition and quantity, administered every hour during 14 h at daytime as well as by GDF during 10 h at night. The frequentmeal regime was introduced in order to imitate GDF and benefit from its supposedly favorable effects. This pseudo-GDF diet was preceded by continuous GDF, day and night, during 3 to 4 wk in order to "titrate" the patient's requirements and tolerance to hyperalimentation.
The patients were free from diseases or abnormalities other than due to their primary disease. Kidney function was evaluated at regular intervals. No signs of complete or incomplete Fanconi's syndrome were observed. The height of the patients was expressed as their HSDS (1 1) calculated from Dutch growth diagrams ( 12).
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METHODS
Urine was collected in 12 h day and night samples by cumulatively freezing each voided urine during the stay of the child in the hospital, or as freshly voided samples both at the end of the night and the day when the child stayed at home. Each urine sample was immediately frozen in the freezer in the hospital, or at the home of the patient and brought to the hospital in the frozen state. Chemical analyses were performed immediately after thawing. Lactate, 2-oxoglutarate, citrate, and glycerol were determined by enzymatic methods (13) . Creatinine was determined by an automated assay. Lactate, citrate, and glycerol were found to be essentially stable during storage at -20" C. The concentration of 2-oxoglutarate was found to be stable for several weeks, if stored at -20" C. However, it decreased by 20-40%, depending on the initial concentration, upon storage at -20" C for more than 6 months. Therefore, this metabolite was determined as soon as possible.
The results of lactate assays of urines obtained at the home of the patient were found to be in agreement with those of the samples obtained in the hospital under steady-state conditions (2) . The lactatelcreatinine, 2-oxoglutarate/creatinine, citratelcreatinine, and glycerol/creatinine ratios were calculated to correct for variations in diuresis and to facilitate the comparison of patients with different ages. The data obtained from urines sampled twice a day during 8 to 10 successive days were averaged to level out fluctuations in the patient's metabolic state because of unknown dietary irregularities or minor infections.
Correlations between variables were determined by Spearman's correlation test. Wilcoxon's sum of rank test was used to determine significance of differences. Correlation of variables and differences between means were considered to be significant i f p < 0.05 (14) .
RESULTS
The mean lactatelcreatinine ratios versus HSDS are presented in Figure 1 . Lactic aciduria was observed in almost all 2 1 patients, even in those with normal growth (HSDS > -1). The higher ratios were found in patients with the lower HSDS values. The predominance of growth-retarded children, with HSDS less than zero, was due to the fact that the sampling period usually was before GDF could have manifested its long-term favorable effect on growth (1). The mean 2-oxoglutarate/creatinine ratios versus HSDS are shown in Figure 2 . Again, the higher ratios were found in patients with the lower HSDS values. Both lactatelcreatinine and 2-oxoglutarate/creatinine ratios were significantly (inversely) correlated with HSDS ( p < 0.005 and 0.025 < p < 0.05, respectively).
The mean lactatelcreatinine ratios versus mean 2-oxoglutaratelcreatinine ratios of all 21 patients are shown in Figure 3 . Taking 0.06 as the upper limit of normal lactatelcreatinine ratios (15) and 0.05 as the upper limit of normal 2-oxoglutarate/ creatinine ratios (n = 15, data not shown), an area for the normal ranges was defined. All GSD patients except one were outside this area. The excretions of lactate and 2-oxoglutarate were significantly (positively) correlated (0.025 < p < 0.05). In normal children there was no correlation (p > 0.1, results not shown).
To determine whether severe growth retardation was reflected in a great variability of lactate and/or 2-oxoglutarate excretion, the SD of the geometric mean for each patient was correlated with HSDS. However, no significant correlation, either positively or inversely, was found ( p > 0.1, results not shown). The mean citratelcreatinine ratios of all 2 1 GSD patients varied from 0.04 to 0.41 as compared to a range of 0.12 to 0.73 in normal children (n = 15), and the mean glycerol/creatinine ratio of all 2 1 GSD patients varied from 0.0 1 to 0.12 as compared to a range of 0.005 to 0.03 in normal children (n = 15). Both were, therefore, not significantly different from normal. Lactic aciduria is known to be influenced by the amount of glucose administered in GDF: a glucose supply below the theoretically calculated requirement (16) elicits excessive lactate excretion (1 5). This phenomenon is not known for 2-oxoglutarate excretion. Therefore, the effect of dietary changes on lactate and 2-oxoglutarate excretion was investigated in longitudinal studies in two patients with the most severe growth retardation. An experimental pseudo-GDF was introduced in order to improve growth and metabolic abnormalities (see "Patients"). As can be seen from Figure 4 , the transition from the routine diet to the pseudo-GDF diet in the first patient was followed by a prompt fall of the lactatelcreatinine ratios below the 2-oxoglutarate/creatinine ratios which decreased little. In the second patient, treated in a similar manner (Table l) , the lactate/creatinine ratio decreased considerably during continuous GDF and pseudo-GDF, both compared with the initial routine diet. It reached the same level as the 2-oxoglutarate/creatinine ratio, which decreased much less. Again, dietary changes appeared to have a strong effect on the lactate/ creatinine ratio and much less on the 2-oxoglutarate/creatinine ratio. In the latter patient, the mean citratelcreatinine ratio increased during pseudo-GDF, but remained well within the normal range (Table 1) . DISCUSSION The excretion in the urine of the metabolites, selected in this study, is determined by two main factors: the rate of production and the renal clearance. Lactate is the end product of glycolysis when the rate of glucose breakdown exceeds the rate of pyruvate oxidation in tissues. In the kidney tubulus lactate is reabsorbed by a specific transporter, shared with ketone bodies and uric acid
2-Oxoglutarate plays a key role in the transport of reduction equivalents from glycolytically generated NADH across the mitochondrial inner membrane to the respiratory chain via the malate-aspartate cycle (1 8) . The origin of 2-oxoglutaric aciduria : ' o~ ing a common transport system in the tubulus (7, 17) . This is 
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genase complex. However, this is difficult to reconcile with the observation that 2-oxoglutaric aciduria may persist, while lactic Fig. 4 . Lactate/creatinine ratio (0) and 2-oxoglutarate/creatinine ra-aciduria almost disappears during hyperalimentation (Fig. 4) , as tio (0) of patient MD with GSD-IA. Diet 1 at home; GDF during 12 h, has been found earlier (19) . This finding does not tally with the irregular meals at daytime, total energy 2100 kcallday. Diet 2 in the supposition that excessive 2-oxoglutarate excretion would be a hospital; GDF during 10 h, pseudo-GDF at daytime, total energy 2330 second "outlet" ofabnormally increasedglycogenolysis, excessive kcal/day. lactate excretion being the first. It would be more compatible with an excessive input of other substrates into the tricarboxylic acid cycle, e.g. for gluconeogenesis. A persistently increased excretion of 2-oxoglutarate would then indicate that the patient's requirement for glucose (and other fuels) is not met and that the energy intake should be increased. This is especially the case if the increased 2-oxoglutarate excretion is accompanied by marked growth retardation. Citrate excretion was not elevated. Rather it appeared to be depressed if the 2-oxoglutarate and lactate excretions were high. The small changes of citrate excretion, reciprocal to those of lactate, might be due to small changes of acid-base equilibrium (20) . Glycerol excretion was not elevated and its determination contributed neither to the evaluation of the metabolic status of the patient nor to better treatment.
We conclude that the determination of both lactate and 2-oxoglutarate in the urine improves the evaluation of the condition of a GSD patient. The level of lactate excretion reflects mainly the adequacy of the diet, while the level of 2-oxoglutarate excretion reflects both the adequacy of the diet and the severity of the disease as manifested by retarded growth, but particularly the latter. It might be used as an indication for intensive treatment of the patient, for instance with hyperalimentation.
